Roshandel G, Ghasemi-Kebria F, Malekzadeh R (2024) Colorectal cancer: epidemiology, risk factors, and prevention. Cancers 16(8):1530

Article  PubMed  PubMed Central  Google Scholar 

Rawla P, Sunkara T, Barsouk A (2019) Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol 14(2):89–103

CAS  PubMed  PubMed Central  Google Scholar 

Deo SVS et al (2021) Colorectal cancers in low- and middle-income countries-demographic pattern and clinical profile of 970 patients treated at a tertiary care cancer center in India. JCO Glob Oncol 7:1110–1115

Article  CAS  PubMed  Google Scholar 

Bregni G et al (2020) Adjuvant chemotherapy for rectal cancer: current evidence and recommendations for clinical practice. Cancer Treat Rev 83:101948

Article  CAS  PubMed  Google Scholar 

Wlodarczyk JR, Lee SW (2022) New frontiers in management of early and advanced rectal cancer. Cancers (Basel). https://doi.org/10.3390/cancers14040938

Article  PubMed  Google Scholar 

Milinis K et al (2015) Adjuvant chemotherapy for rectal cancer: Is it needed? World J Clin Oncol 6(6):225–236

Article  PubMed  PubMed Central  Google Scholar 

Chan GHJ, Chee CE (2019) Making sense of adjuvant chemotherapy in colorectal cancer. J Gastroint Oncol 10(6):1183–1192

Article  Google Scholar 

Poulsen L et al (2015) Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much? Acta Oncol 54(4):437–446

Article  CAS  PubMed  Google Scholar 

Rödel C et al (2015) Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 16(8):979–989

Article  PubMed  Google Scholar 

Breugom AJ et al (2015) Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. Lancet Oncol 16(2):200–207

Article  CAS  PubMed  Google Scholar 

Amin MB et al (2017) The eight edition AJCC cancer staging manual continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. https://doi.org/10.3322/caac.21388

Article  PubMed  PubMed Central  Google Scholar 

Edge SB (2010) American joint committee on cancer. AJCC cancer staging handbook from the AJCC cancer staging manual. Springer, Cham

Google Scholar 

Glynne-Jones R et al (2017) Rectal cancer ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. https://doi.org/10.1093/annonc/mdx224

Article  PubMed  Google Scholar 

Conroy T et al (2024) Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol 35(10):873–881

Article  CAS  PubMed  Google Scholar 

Benson AB et al (2020) Rectal cancer, version 22022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20(10):1139–1167

Article  Google Scholar 

Xiao W-W et al (2018) The total number of lymph nodes harvested from pathological T3N0 rectal cancer patients: prognostic significance and potential indication for postoperative radiotherapy. J Cancer Res Ther 14(Suppl 2):S288–S294

Article  PubMed  Google Scholar 

Lee JH (2019) The role of adjuvant chemotherapy according to the status of surgical margin in rectal cancer. Annal Oncol. https://doi.org/10.1093/annonc/mdz421.019

Article  Google Scholar 

Sung SY et al (2022) Pathologic implications of radial resection margin and perineural invasion to adjuvant chemotherapy after preoperative chemoradiotherapy and surgery for rectal cancer: a multi-institutional and case-matched control study. Cancers (Basel). https://doi.org/10.3390/cancers14174112

Article  PubMed  PubMed Central  Google Scholar 

van Eeghen EE et al (2015) Impact of age and comorbidity on survival in colorectal cancer. J Gastrointest Oncol 6(6):605–612

PubMed  PubMed Central  Google Scholar 

Pilleron S et al (2023) Age-related differences in colon and rectal cancer survival by stage, histology, and tumour site: an analysis of United States SEER-18 data. Cancer Epidemiol 84:102363

Article  PubMed  Google Scholar 

Petrelli F et al (2015) A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer. Int J Colorectal Dis 30(4):447–457

Article  PubMed  Google Scholar 

Petersen SH et al (2012) Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004078.pub2

Article  PubMed  PubMed Central  Google Scholar 

Sainato A et al (2014) No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): long term results of a randomized trial (I-CNR-RT). Radiother Oncol 113(2):223–229

Article  PubMed  Google Scholar 

Bosset JF et al (2014) Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 15(2):184–190

Article  CAS  PubMed  Google Scholar 

Hong YS et al (2019) Oxaliplatin-based adjuvant chemotherapy for rectal cancer after preoperative chemoradiotherapy (ADORE): long-term results of a randomized controlled trial. J Clin Oncol 37(33):3111–3123

Article  CAS  PubMed  Google Scholar 

Maas M et al (2015) Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients. Int J Cancer 137(1):212–220

Article  CAS  PubMed  Google Scholar 

Polanco PM et al (2018) Association of adjuvant chemotherapy with overall survival in patients with rectal cancer and pathologic complete response following neoadjuvant chemotherapy and resection. JAMA Oncol 4(7):938–943

Article  PubMed  PubMed Central  Google Scholar 

Loree JM et al (2018) Impact of postoperative adjuvant chemotherapy following long-course chemoradiotherapy in stage II rectal cancer. Am J Clin Oncol 41(7):643–648

Article  PubMed  Google Scholar 

Liao H et al (2023) Adjuvant chemotherapy does not improve cancer-specific survival for pathologic stage II/III rectal adenocarcinoma after neoadjuvant chemoradiotherapy and surgery: evidence based on long-term survival analysis from SEER data. Int J Colorectal Dis 38(1):134

Article  PubMed  Google Scholar 

Ducreux M et al (2011) Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer. Int J Cancer 128(3):682–690

Article  CAS  PubMed  Google Scholar